|
10/04/07 |
GeneBio announces the release of
Phenyx version 2.5 |
|
|
|
|
10/02/07 |
BMS:Survival
Data In FDA Approval For ERBITUX® (Cetuximab) Supports Use As A Single
Agent In Patients With Advanced Colorectal Cancer |
|
|
|
|
|
GSK applies for licence to market OTC weight loss product In Europe
|
|
|
|
|
10/01/07 |
Applied Biosystems Announces Co-Development Agreement with Olink
Bioscience |
|
|
|
|
9/20/07 |
GeneBio and the SIB Launch an
Extended Version of Aldente, SIB's Peptide
Mass Fingerprint Tool |
|
|
|
|
|
The Proteomics Research
Group (PRG) of the Association of Biomolecular Resource Facilities
(ABRF) would like to invite you to participate in a study that explores
the use of different approaches for determining qualitative differences
between two similar samples. |
|
|
|
|
09/18/07 |
Millenium:
Phase III Clinical Trial in Newly Diagnosed Multiple Myeloma Stopped
Early Due to Highly Significant Efficacy Advantage of VELCADE(R) (Bortezomib)
for Injection Based Therapy Across All Endpoints |
|
|
|
|
|
Merck:
One-Year Data Showed Investigational Use of Initial Combination Therapy
with JANUVIA™ (sitagliptin) and Metformin Significantly Improved Blood
Sugar Control in Patients with Type 2 Diabetes Compared to Metformin
Alone |
|
|
|
|
09/17/07 |
Sanofi-Aventis Developing New Drugs, link to article at The San
Francisco Chronicle |
|
|
|
|
|
Celera and
Collaborators Identify Gene Variants Predicting Susceptibility to, and
Severity of, Rheumatoid Arthritis |
|
|
|
|
09/14/07 |
FDA Approves Lilly's Osteoporosis Drug EVISTA® (raloxifene HCl) to
Reduce The Risk of Invasive Breast Cancer in Two Populations of
Postmenopausal Women |
|
|
|
|
|
Bruker Daltonics Announces Contract Award for Phase III of the ARFCAM
Program by the U.S. Department of Homeland Security |
|
|
|
|
09/13/07 |
Gene therapy death raises ethical issues, link to article at The San Francisco Chronicle
|
|
|
|
|
|
GeneBio's Phenyx Integrated with
Institute for System Biology's TPP |
|
|
|
|
09/11/07 |
GlaxoSmithKline and Sepracor Inc. announce international alliance for
commercilisation of Lunivia |
|
|
|
|
09/07/07 |
Court Rules in Favor of Applied Biosystems in Patent Suit with Enzo
Biochem, Inc. |
|
|
|
|
09/05/07 |
Thermo Fisher Scientific Acquires Instrument Sales Business of Davis
Inotek |
|
|
|
|
|
Applied Biosystems Expands Portfolio of Services for Mass Spectrometry
Instrument Systems |
|
|
|
|
09/04/07 |
Applied Biosystems Announces Software Development Initiative for
Next-Generation Sequencing |
|
|
|
|
08/28/07 |
Amgen:
Court Rules That Roche Infringes One of Amgen's Erythropoietin Patents
|
|
|
|
|
08/27/07 |
Geron Scientists and
Collaborators Demonstrate Human Embryonic Stem Cell-Derived
Cardiomyocytes Improve Heart Function When Transplanted After Myocardial
Infarction |
|
|
|
|
08/24/07 |
Vermillion (Formerly Ciphergen) Announces $20.5 Million Private
Placement of Common Stock |
|
|
|
|
|
Roche:
Avastin approved in
Europe for first-line treatment of patients with advanced lung cancer |
|
|
|
|
08/21/07 |
CEO for Biotech firm PDL leaving after battle with shareholder firm, link to article at The San Francisco Chronicle
|
|
|
|
|
08/20/07 |
Biogen Idec:
TYSABRI®
Demonstrates Significant Health-Related Quality-of-Life Improvements for
Multiple Sclerosis Patients in Study Published in Annals of Neurology
|
|
|
|
|
08/17/07 |
Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock
Market |
|
|
|
|
08/16/07 |
Biotech giant Amgen to cut 2,000-plus jobs, link to article at The San Francisco Chronicle
|
|
|
|
|
08/13/07 |
Alza Corp. leaving Mountain View after 17
years |
|
|
|
|
08/07/07 |
BMS:
ORENCIA® (abatacept) Supplemental Biologics License Application for
Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review |
|
|
|
|
08/06/07 |
Venture capital invests $7.1 billion in 2nd quarter, link to article at The San Francisco Chronicle
|
|
|
|
|
|
CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE
Clinical Development Programs |
|
|
|
|
08/03/07 |
Genentech completes acquisition - $919 million for Tanox is its first
purchase ever, link to article at The San Francisco Chronicle
|
|
|
|
|
|
GSK:
FDA issues second approvable letter for Trexima™ |
|
|
|
|
08/02/07 |
GSK comments on UK Government announcement to renegotiate current
Pharmaceutical Pricing and Regulation Scheme agreement |
|
|
|
|
|
Genentech Announces Expiration of Hart-Scott-Rodino Waiting Period and
Completes Acquisition of Tanox |
|
|
|
|
07/31/07 |
Biogen Idec:
Joint FDA
Advisory Committee Recommends Approval of TYSABRI® for the Treatment of
Moderate to Severe Crohn's Disease |
|
|
|
|
07/26/07 |
Roche:
Roche extends tender
offer for Ventana |
|
|
|
|
|
Roche:
Mircera approved in
European Union for treatment of anemia related to chronic kidney
disease |
|
|
|
|
|
Millennium Highlights Strong Second-Quarter Results and Upcoming Growth
Catalysts |
|
|
|
|
|
Abbott and Genentech Announce Global, Integrated Research, Development
and Commercialization Collaboration in Oncology |
|
|
|
|
07/25/07 |
Turning up the heat on biotech, and PDL, link to article at The San Francisco Chronicle
|
|
|
|
|
07/20/07 |
Roche:
Avastin receives
positive opinion in Europe for first-line treatment of patients with
advanced lung cancer |
|
|
|
|
07/1907 |
Roche:
Roche in the first
half of 2007: Strong performance continues |
|
|
|
|
|
Elan and
Biogen Idec Preparing to Appeal Ruling on European Application for
Natalizumab for the Treatment of Crohn's Disease |
|
|
|
|
07/18/07 |
GSK’s cervical cancer candidate vaccine Cervarix™ receives positive
opinion in Europe for prevention of cervical cancer |
|
|
|
|
|
Amgen Completes Acquisition of Ilypsa |
|
|
|
|
07/16/07 |
Thermo Fisher Scientific Launches NITON XL3 Series of Portable Elemental
Analyzers |
|
|
|
|
|
Millennium Initiates Phase III Trial to Determine the Optimal VELCADE(R)
(Bortezomib) for Injection Based Therapy in Newly Diagnosed Multiple
Myeloma Patients |
|
|
|
|
|
ROTATEQ® and GARDASIL® Adopted by All Immunization Projects of the
Centers for Disease Control and Prevention's (CDC) Vaccines for Children
(VFC) Program |
|
|
|
|
|
Seattle: Will finances delay Amgen project? , link to article at The Seattle
Times |
|
|
|
|
07/12/07 |
SEC looks at deals by Dendreon - Biotech company's interactions with FDA
under scrutiny, link to article at The San Francisco Chronicle
|
|
|
|
|
|
BMS:
Data Available From ERBITUX® Phase III Study in First-Line Treatment of
Advanced Lung Cancer |
|
|
|
|
|
Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
|
|
|
|
|
07/09/07 |
Roche and Alnylam form
major alliance on RNAi therapeutics |
|
|
|
|
|
Geron Initiates
Clinical Trial of Telomerase Inhibitor Drug in Combination with
Paclitaxel and Carboplatin in Patients with Non-Small Cell Lung Cancer |
|
|
|
|
|
CV Therapeutics Identifies Potential Anti-Diabetic Mechanism of Action
for Ranexa(R) |
|
|
|
|
07/03/07 |
TYSABRI®
Recommended by Nice for Use in Highly Active Relapsing Remitting
Multiple Sclerosis in the Final Appraisal Determination |
|
|
|
|
06/27/07 |
Roche:
Preliminary results
for phase III study evaluating CellCept in lupus nephritis |
|
|
|
|
|
GSK:
Largest cervical cancer vaccine efficacy trial shows Cervarix™ provides
excellent protection against lesions caused by most common
cancer-causing virus types |
|
|
|
|
06/26/07 |
GeneBio and GE Healthcare have
recently agreed to extend their collaboration and to jointly distribute
Melanie |
|
|
|
|
|
Abbott and Genentech Announce Global, Integrated Research, Development
and Commercialization Collaboration in Oncology
|
|
|
|
|
|
UCB and
Biogen Idec's Oral VLA-4 Antagonist Enters Phase II Development for
Multiple Sclerosis |
|
|
|
|
06/25/07 |
Roche makes offer to
acquire Ventana for 75 US dollars per share in cash |
|
|
|
|
|
Roche and Toyama
Chemical enter licensing agreement to develop potential breakthrough
drug to treat rheumatoid arthritis |
|
|
|
|
|
Once monthly Mircera
could save about 50% of the time health professionals spend on anaemia
management in dialysis centres each year |
|
|
|
|
06/24/07 |
Novartis:
Lucentis® receives approval in the European Union - the first drug to
improve vision in patients with wet AMD, a leading cause of blindness |
|
|
|
|
06/20/07 |
Bayer CropScience and Monsanto enter long-term business and license
agreements for key enabling technologies |
|
|
|
|
|
Applied Biosystems:
Scientists Discover New Role for MicroRNAs in Stopping Tumor Cell Growth |
|
|
|
|
|
PerkinElmer Establishes Wholly Owned Subsidiary in India |
|
|
|
|
06/19/07 |
Roche acquires
NimbleGen to gain entry into high-growth research microarrray market |
|
|
|
|
|
Thermo Fisher Scientific Launches RNAi Services Laboratory Supporting
Researchers in Drug Discovery and Development |
|
|
|
|
|
Myriad Genetics
Collaborates With AstraZeneca on Phase 2 Trials |
|
|
|
|
|
Research Documents
Scalable Production, Survival Following Engraftment and Positive Impact
On Cardiac Function in Infarcted Rats for Geron¡¦s Human Embryonic Stem
Cell-Based Therapeutic for Heart Failure |
|
|
|
|
|
Sanofi-Aventis and Bristol-Myers Squibb Prevail in U.S. Plavix Patent
Litigation |
|
|
|
|
|
FDA Grants Priority Review for Bristol-Myers Squibb's Investigational
Oncology Treatment Ixabepilone |
|
|
|
|
06/18/07 |
GlaxoSmithKline expects to launch up to five major new medicines for
oncology in next three years |
|
|
|
|
06/15/07 |
GlaxoSmithKlline and Genmab present positive Phase II results with
ofatumumab in patients with rheumatoid arthritis (RA) |
|
|
|
|
|
Actemra: Roche´s novel
rheumatoid arthritis drug shows substantial benefits for patients in
OPTION study |
|
|
|
|
06/14/07 |
Drug sales could double by 2020 - Report says traditional pharmaceutical
companies must become more innovative, link to article at The San Francisco Chronicle |
|
|
|
|
06/12/07 |
Biotech firm's stock jumps on Alzheimer's data - Medivation's Dimebon
helped patients in small, one-year trials, link to article at The San Francisco Chronicle |
|
|
|
|
|
|
|
06/11/07 |
BMS:
FDA Accepts and Grants Priority Review of Erbitux® (Cetuximab) sBLA for
Overall Survival in Patients With Advanced Colorectal Cancer |
|
|
|
|
|
GSK:
Pivotal phase III trial showed RevoladeTM (eltrombopag) raised platelet
counts and reduced bleeding in patients with chronic ITP |
|
|
|
|
06/10/07 |
Biotech pioneer defends its turf - Genentech is busy on new therapies to
combat cancer, link to article at The San Francisco Chronicle |
|
|
|
|
|
Abbott's HUMIRA® (Adalimumab) Approved in the European Union for the
Treatment of Crohn's Disease |
|
|
|
|
06/06/07 |
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology
Company in Cambridge, Massachusetts |
|
|
|
|
|
Roche recalls
Viracept due to chemical impurity |
|
|
|
|
06/04/07 |
Thermo Fisher Scientific Expands Industry-leading Mass Spectrometry
Portfolio Introduces New Integrated Solutions for Protein Research,
Cellular Science and General Laboratory Applications |
|
|
|
|
06/03/07 |
Study: Avastin expands reach - Genetech product found to work on kidney
tumors, link to article at The San Francisco Chronicle |
|
|
|
|
06/01/07 |
AstraZeneca's MedImmune Bid a 'Success', link to article at The San
Francisco Chronicle |
|
|
|
|
05/31/07 |
GeneBios Phenyx Integrated with
Proteome Softwares Scaffold |
|
|
|
|
05/29/07 |
Brainstorming about the brain - Entrepreneur pioneers systems to allow
neuroscientists to share their discoveries,
link to article at The San Francisco Chronicle |
|
|
|
|
|
New AIDS Technology
Transfers free of charge reinforce Roche´s commitment to strengthen
local manufacturing in Africa |
|
|
|
|
|
Small biotech firm Novacea lands big partner - Schering-Plough will help
develop cancer treatment, link to article at The San Francisco
Chronicle |
|
|
|
|
05/26/07 |
STANFORD - Research may improve prostate risk screening - DNA findings
could identify men most likely to get cancerSmall
biotech firm Novacea lands big partner - Schering-Plough will help
develop cancer treatment |
|
|
|
|
|
Abbott Diagnostics Issues Voluntary Nationwide Recall of ARCHITECT® STAT
Troponin-I Test |
|
|
|
|
05/23/07 |
Now Google is grooming a biotech firm - Company invests $3.9 million in
business begun by Brin's bride,
link to article at The San Francisco Chronicle |
|
|
|
|
05/21/07 |
BMS:
BARACLUDE® (Entecavir) Treatment Demonstrated Greater Viral Load
Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive
Chronic Hepatitis B E-Antigen Positive Patients |
|
|
|
|
|
GSK:
Cervarix is approved in Australia
for females 10-45 years old |
|
|
|
|
|
Thermo Fisher Scientific and Quintiles Create Joint Venture to Provide
Integrated Response Technology Services |
|
|
|
|
|
Geron Scientists and
Collaborators Differentiate Human Embryonic Stem Cells Into
Insulin-Producing Islet-Like Clusters |
|
|
|
|
05/18/07 |
FDA Stops Short of Approving Roche Drug,
link to article at The San Francisco Chronicle |
|
|
|
|
|
Roche:
Roche receives
approvable letter for Mircera in the United States |
|
|
|
|
|
Amgen Recommends Rejection of Mini-Tender Offer by TRC Capital
Corporation |
|
|
|
|
05/17/07 |
1'000'000'000 connections to
the ExPASy server! |
|
|
|
|
05/14/07 |
Highly sensitive and
accurate Roche HIV-1 Test approved by FDA |
|
|
|
|
|
Supreme Court turns down Amgen's
appeal in patent case,
link to article at The San Francisco Chronicle |
|
|
|
|
05/13/07 |
Merck Selling Generics Unit for $6.6B, link
to article at The San Francisco Chronicle |
|
|
|
|
05/11/07 |
GlaxoSmithKline’s Hib-MenCY-TT combination vaccine meets phase II study
endpoints of immunogenicity and safety compared to licensed vaccines
|
|
|
|
|
05/09/07 |
Bristol-Myers Squibb Enters Cardiovascular Disease Collaboration With
Isis Pharmaceuticals
Collaboration to Focus on Antisense Inhibitors of PCSK9 |
|
|
|
|
05/08/07 |
Massachusetts governor proposes $1 billion for stem-cell research, link
to article at The San Francisco Chronicle |
|
|
|
|
|
Merck:
FDA Approves New Dosage Strength of FOSAMAX PLUS D (alendronate sodium/cholecalciferol),
Increasing Vitamin D Intake for Patients with Osteoporosis |
|
|
|
|
05/03/07 |
Lilly:
Data Suggest Cymbalta® Reduced Severity of Night Pain in Patients with
Diabetic Nerve Pain |
|
|
|
|
|
Roche:
Herceptin approved in
Europe for use in combination with an aromatase inhibitor for the
treatment of patients with HER2 and hormone receptor-co-positive
metastatic breast cancer |
|
|
|
|
05/02/07 |
Thermo Fisher Scientific to Host Annual Meeting of Shareholders on May
15, 2007 |
|
|
|
|
|
GlaxoSmithKline supports World Health Organization efforts to strengthen
global pandemic preparedness plans |
|
|
|
|
05/01/07 |
Bayer:
Immediate Treatment of Early MS Patients with Betaferon® Significantly
Delayed Permanent Disability |
|
|
|
|
|
GSK:
FDA Advisory Committee finds substantial evidence to support Advair
500/50 in reducing COPD exacerbations |
|
|
|
|
|
Genentech:
Rituxan Phase II Data in Patients with Relapsing-Remitting Multiple
Sclerosis Presented at the American Academy of Neurology |
|
|
|
|
04/30/07 |
Senate Considers Bill to Overhaul FDA, link
to article at The San Francisco Chronicle |
|
|
|
|
|
Amgen:
Final Vectibix(TM) Positive Pivotal Phase 3 Trial Results In Metastatic
Colorectal Cancer Patients Published |
|
|
|
|
04/26/07 |
Roche update on
Tamiflu for pandemic influenza preparedness |
|
|
|
|
|
PDL BioPharma Advances Nuvion(R) Into Second Pivotal Study in
Intravenous Steroid-Refractory Ulcerative Colitis |
|
|
|
|
04/24/07 |
Novartis:
Lucentis® receives approval in the European Union - the first drug to
improve vision in patients with wet AMD, a leading cause of blindness |
|
|
|
|
|
PDL BioPharma's European Patent Claims Upheld |
|
|
|
|
04/23/07 |
AstraZeneca to Buy MedImmune, link
to article at The San Francisco Chronicle |
|
|
|
|
|
Applied Biosystems/MDS SCIEX Announces New Proteomics Tools for
Biomarker Research |
|
|
|
|
04/20/07 |
Scientists see hope for new AIDS drug , link
to article at The San Francisco Chronicle |
|
|
|
|
|
Genentech Extends Stock Repurchase Program |
|
|
|
|
04/19/07 |
Studies Confirm
Proof-of-Principle for Geron’s Human Embryonic Stem Cell (hESC) Derived
Hepatocytes |
|
|
|
|
|
Gilead Announces Presentation of Positive Phase III Data on Aztreonam
Lysine for Inhalation in Patients With Cystic Fibrosis
|
|
|
|
|
04/18/07 |
Roche:
Breakthrough cancer
drug Avastin approved in Japan for use in advanced or recurrent
colorectal cancer |
|
|
|
|
|
GlaxoSmithKline receives Japanese approval for two major new product
opportunities: Seretide/Advair and Arixtra |
|
|
|
|
04/17/07 |
Biotech firms strong in 2006 - Net loss increased, mostly because of
major acquisitions, link
to article at The San Francisco Chronicle |
|
|
|
|
|
Medarex Presents Preclinical Data Demonstrating Potent Anti-Tumor
Activity of Anti-CD19 and Anti-CD70 Antibody-Drug Conjugates in Cancer
Animal Models |
|
|
|
|
|
Early Drug Discovery Expected to Improve with First-of-its-Kind Mass
Spectrometry Platform from Applied Biosystems/MDS SCIEX |
|
|
|
|
04/14/07 |
Low-priced stocks, high-flying volatility - Biotech firms sometimes have
wild weeks as speculators rush in, then out, link
to article at The San Francisco Chronicle |
|
|
|
|
|
Biotech Seeks to Ease Reliance on Corn, link
to article at The San Francisco Chronicle |
|
|
|
|
04/13/07 |
Abbot:
Abbott Researchers Focus on New Cutting-Edge Approaches in the Fight
Against Cancer |
|
|
|
|
|
BMS
BARACLUDE® (entecavir) Therapy Resulted in Undetectable
Levels of Hepatitis B Virus in Cohort of Patients Who Re-Started
Treatment |
|
|
|
|
|
Biogen Idec:
New One-Year Pharmacoeconomic Study Shows AVONEX® is
Cost-Effective Relative to Other Interferon Therapies for Multiple
Sclerosis |
|
|
|
|
04/11/07 |
Genentech Announces First Quarter
2007 Results |
|
|
|
|
04/10/07 |
Amgen's CFO resigns amid biotech
titans struggles, link
to article at The San Francisco Chronicle
|
|
|
|
|
|
Amgen Names Robert Bradway Executive Vice President and
Chief Financial Officer |
|
|
|
|
|
Abbott Agrees with World Health Organization (WHO) Director-General to
Expand Access to Kaletra/Aluvia (lopinavir/ritonavir) |
|
|
|
|
04/09/07 |
Ciphergen Biosystems' Auditors Expressed Going-Concern Qualification |
|
|
|
|
|
Caliper Life Sciences to Explore Novel Indications for Drug Candidates |
|
|
|
|
04/06/07 |
Abbott Announces FDA Approval of a New Coated Niaspan Tablet |
|
|
|
|
04/04/07 |
Roche to acquire
BioVeris to expand its leading ECL immunochemistry business into new
market segments |
|
|
|
|
|
MDS Nordion Enters Collaboration Agreement with Avid
Radiopharmaceuticals on Imaging Compounds for Alzheimer's Disease |
|
|
|
|
|
BMS:
Survival Data Available From ERBITUX® Study in First-Line Treatment of
Advanced Head and Neck Cancer |
|
|
|
|
04/02/07 |
PerkinElmer Acquires Improvision Ltd. |
|
|
|
|
|
Merck:
FDA Approves JANUMET™ for Type 2 Diabetes, Offering Powerful Glucose
Control of a DPP-4 Inhibitor and Metformin in a Single Tablet
|
|
|
|
|
|
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA® (Adalimumab)
in Psoriasis |
|
|
|
|
|
Agilent Technologies Launches New Inductively Coupled Mass Spectrometer
Delivering Higher Productivity, More Accurate Results |
|
|
|
|
03/27/07 |
GeneBio Launches Novel Online
Platform for Protein Identification |
|
|
|
|
|
Bayer to take over Novartis drug plant - Site
manufactures multiple sclerosis drug Betaseron
|
|
|
|
|
03/24/07 |
Genentech projects quarter to be 'flat' - Earnings growth
still expected for rest of the year
|
|
|
|
|
03/22/07 |
CDC Finalizes Advisory Panel Recommendations for GARDASIL®, Merck's
Cervical Cancer Vaccine |
|
|
|
|
|
Amgen Discontinues Vectibix(TM) Treatment In PACCE Trial Evaluating
Vectibix(TM) As Part Of Triple Combination Regimen |
|
|
|
|
|
The little biotech company that could - Onyx finds success with cancer
drug, Bayer partnership, link to article at The San Francisco
Chronicle |
|
|
|
|
|
The Basel Biozentrum
Taps Phenyx as Protein Identification Platform |
|
|
|
|
03/21/07 |
Biofuels Spark Biotech Rally, link to
article at The San Francisco Chronicle
|
|
|
|
|
03/20/07 |
Pfizer Wins Celebrex Patent Challenge by Generic Manufacturer Teva |
|
|
|
|
|
Myriad Genetics
Completes Enrollment in Second Phase 3 Clinical Trial of Flurizan™ in
Alzheimer's Disease |
|
|
|
|
03/15/07 |
FDA: Biotech Knockoffs Earn Lower Status, link to
article at The San Francisco Chronicle
|
|
|
|
|
03/14/07 |
Bristol-Myers Squibb Significantly Expands Research And Development
Presence In India Through Collaborations With Biocon And Accenture |
|
|
|
|
|
MDS Extends Cash Tender Offer for All Outstanding Shares of Molecular
Devices Corporation |
|
|
|
|
03/12/07 |
PDL:
Primary Endpoint Met in Phase 2 Trial of Daclizumab in Patients With
Relapsing Multiple Sclerosis |
|
|
|
|
03/11/07 |
When clinical trial results just say 'no' - Biotech companies often are
able to bounce back from seeming disaster, thanks to deep reserves and
partnerships, link to
article at The San Francisco Chronicle
|
|
|
|
|
|
Amgen:
Amgen Announces Update To U.S. Prescribing Information for Aranesp(R)
and EPOGEN(R) |
|
|
|
|
03/08/07 |
Oncology Nursing gets $1 million Genentech Inc. grant, link to
article at The San Francisco Chronicle
|
|
|
|
|
|
Thermo Fisher Scientific's New ETD Mass Spectrometry Technology Wins
Silver Award at PITTCON 2007 |
|
|
|
|
03/07/07 |
Partners Tercica, Genentech settle patent dispute with competitor, link to
article at The San Francisco Chronicle
|
|
|
|
|
03/06/07 |
Amgen hurt when Medicare drops anemia drug, link to
article at The San Francisco Chronicle
|
|
|
|
|
03/05/07 |
Roche raises dividend
by 36 percent |
|
|
|
|
|
New studies indicate GSK’s pre-pandemic influenza vaccine can protect
against different strains of H5N1 |
|
|
|
|
|
Ciphergen Presents Data Validating Ovarian Cancer Triage Test at Society
of Gynecologic Oncologists Annual Meeting |
|
|
|
|
|
New studies indicate GSK’s pre-pandemic influenza vaccine can protect
against different strains of H5N1 |
|
|
|
|
03/02/07 |
Pfizer: Lipitor Significantly Reduced the Risk of Serious Cardiovascular
Events Compared With Simvastatin in an 80,000-Patient Analysis of a
Real-World Managed Care Database |
|
|
|
|
03/01/07 |
Thermo Fisher Scientific to Buy Back Its Common Stock |
|
|
|
|
|
GSK:
Study published in New England Journal of Medicine: Vaccine 95.5%
effective against neglected hepatitis E |
|
|
|
|
|
Pfizer's Maraviroc, Novel Medicine for HIV, Significantly Reduces Viral
Load, in Combination Therapy Across Range of Treatment-Experienced
Patients |
|
|
|
|
|
Gilead Announces 24-Week Results from Phase II Study of Investigational
HIV Integrase Inhibitor GS 9137 |
|
|
|
|
02/28/07 |
Applied Biosystems/MDS SCIEX's Software Development Initiative Targets
Drug Discovery with Rapid Analysis of Compounds |
|
|
|
|
02/27/07 |
Pfizer Wins Challenge to Norvasc Patent by Mylan |
|
|
|
|
|
HUMIRA® (adalimumab) Receives FDA Approval for Treatment of Crohn's
Disease |
|
|
|
|
|
Celera Identifies
Novel Genes Associated with Late-Onset Alzeimer's Disease |
|
|
|
|
|
Geron Corporation
Announces Exercise Of Warrants for $15.0 Million of Proceeds |
|
|
|
|
02/26/07 |
Roche:
Positive
recommendation for Avastin use in advanced or recurrent colorectal
cancer in Japan |
|
|
|
|
|
Agilent Technologies Expands Use of HPLC Chip to Entire LC Mass
Spectrometry Portfolio |
|
|
|
|
|
MDS Finalizes Sale of Diagnostics Business to Borealis Infrastructure in
$1.3B Transaction |
|
|
|
|
|
Bristol-Myers Squibb Company and Adnexus Therapeutics Announce
Collaboration to Develop and Commercialize Innovative Oncology Compounds |
|
|
|
|
|
GSK initiates first global Phase III study of Tykerb® (lapatinib) in
head and neck cancer |
|
|
|
|
02/23/07 |
Roche:Oral
cancer drug Xeloda receives positive opinion from the European
Authorities for the treatment of advanced gastric cancer |
|
|
|
|
|
Roche:Avastin
receives positive opinion in Europe for first-line treatment of women
with metastatic breast cancer |
|
|
|
|
|
Pfizer: Danish Court Issues Preliminary Injunction That Prohibits Sale
of Generic Lipitor Product |
|
|
|
|
02/22/07 |
Roche:New
phase III study confirms positive outcome of Avastin in patients with
advanced lung cancer |
|
|
|
|
|
Medarex:
Cell
Genesys and Medarex Announce Encouraging Follow-Up Results from a Phase
1 Combination Therapy Trial With GVAX(TM) Immunotherapy for Prostate
Cancer and Ipilimumab (MDX-010) Antibody |
|
|
|
|
|
Lilly Introduces World's First Digital Insulin Pen With Memory |
|
|
|
|
|
Celera Presents
Data Validating Its Metastasis Score as a Molecular Prognostic Tool in
Breast Cancer |
|
|
|
|
|
Thermo Fisher Scientific Announces Chromatography
Software Control For the High Speed Accela LC
Enabling Fast and Efficient Data Analysis |
|
|
|
|
02/21/07 |
GSK:
Landmark study shows important benefits of Seretide™ treatment for
patients with fatal lung disease, COPD |
|
|
|
|
|
|
|
02/20/07 |
Compugen Announces Discovery of Eight Novel G-Protein Coupled Receptor
(GPCR) Peptide Ligands |
|
|
|
|
|
Roche and GSK agree on two
transactions |
|
|
|
|
|
Medarex Announces Sale of Shares in Genmab A/S |
|
|
|
|
02/16/07 |
GlaxoSmithKline successfully completes tender offer for shares of
Praecis Pharmaceuticals |
|
|
|
|
|
Lilly:
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to
Clopidogrel in Patients With Acute Coronary Syndrome |
|
|
|
|
|
Agilent Technologies Announces Shipment of 1,000th Rapid Resolution
Liquid Chromatography System |
|
|
|
|
02/15/07 |
Geron:
Unique Structure of
Geron’s Telomerase Inhibitor Drug Promotes Anti-Tumor, Anti-Metastatic
Activity in Lung Cancer Cells |
|
|
|
|
02/14/07 |
Generic Biotech Drugs Could Save $71B, link to
article at The San Francisco Chronicle
|
|
|
|
|
|
Ciphergen Initiates Clinical Trial for Ovarian Cancer Triage Test |
|
|
|
|
02/13/07 |
WHO awards prequalification status to GSK rotavirus vaccine |
|
|
|
|
02/12/07 |
Bruker BioSciences Announces Closing of Common Stock Offering |
|
|
|
|
02/11/07 |
UC Berkeley's bioenergy research pact with oil giant BP, link to
article at The San Francisco Chronicle |
|
|
|
|
02/08/07 |
Natural brain substance linked to Parkinson's symptoms, link to
article at The San Francisco Chronicle
|
|
|
|
|
|
MDS Nordion Establishes European Centers of Excellence for Innovative
Liver Cancer Therapy |
|
|
|
|
|
Millennium Exceeds Non-GAAP Profitability Goal and Narrows GAAP Net Loss
by 78%(1) |
|
|
|
|
|
Gilead and Achillion Announce Positive Antiviral
Activity of NS4A Antagonist in HCV, But Discontinue GS 9132 (ACH-806)
Development |
|
|
|
|
02/07/07 |
Roche posts
outstanding results for 2006 |
|
|
|
|
|
Biogen
Idec Initiates Randomized, Registrational Trial of Lumiliximab for
Chronic Lymphocytic Leukemia |
|
|
|
|
02/05/07 |
ImClone Systems Incorporated and Bristol-Myers Squibb Announce
Application In Japan for Use of ERBITUX in Metastatic Colorectal Cancer |
|
|
|
|
|
Genentech Announces Positive Results from a Phase IV Study of Raptiva in
Patients With Moderate-to-Severe Hand and Foot Psoriasis |
|
|
|
|
|
Amgen:
Survey Indicates People with Chronic Moderate to Severe Plaque Psoriasis
May Be Under-Treated |
|
|
|
|
02/02/07 |
GlaxoSmithKline receives
approvable letter for new indications for Arixtra® |
|
|
|
|
02/01/07 |
The first U.S. approval for a prostate cancer vaccine may go to
Seattle's Dendreon Corp. |
|
|
|
|
01/31/07 |
CellTherapeutics will restate results for three quarters, link to
article at The Seattle Times |
|
|
|
|
|
Eli Lilly completes Icos takeover, link to
article at The Seattle Times |
|
|
|
|
01/30/07 |
Merck
4th-Quarter Profit Drops 58 Percent. |
|
|
|
|
01/29/07 |
MDS Offers to Acquire Molecular Devices for US$615 Million in Major
Expansion of MDS Sciex Business |
|
|
|
|
|
Bayer:
Acquisition of Schering AG / Squeeze-out - Full Details |
|
|
|
|
|
GlaxoSmithKline files its new pre-pandemic influenza vaccine in Europe
|
|
|
|
|
|
Genentech and Tanox Receive "Second Request" from the Federal Trade
Commission |
|
|
|
|
|
Roche:
Tarceva : European
approval for pancreatic cancer treatment |
|
|
|
|
|
Ciphergen Announces Publication of Data Describing Application for
Evaluating Patients with Blood Disorder |
|
|
|
|
01/26/07 |
Amgen profit up 1% as spending soars , link to
article at The Seattle Times |
|
|
|
|
|
Roche:
Copegus approved in
Japan as combination therapy with Pegasys for patients with chronic
hepatitis C |
|
|
|
|
|
Genetech slips after stroke warning in blindness treatment, link to
article at The San Francisco Chronicle |
|
|
|
|
01/25/07 |
Icos sale to Lilly approved by shareholders, link to
article at The Seattle Times |
|
|
|
|
|
Ciphergen Announces Issuance of European Patent Covering a Method for
Aiding Prostate Cancer Diagnosis |
|
|
|
|
|
Amgen:
Amgen's Fourth Quarter 2006 Revenue Increased 17% to $3.8 Billion; Full
Year 2006 Revenue Increased 15% to $14.3 Billion |
|
|
|
|
01/24/07 |
Roche:First
Actemra multinational phase III trial demonstrates significant
improvement in signs and symptoms of rheumatoid arthritis |
|
|
|
|
|
Cell Therapeutics agrees to settle in investigation of cancer-drug
marketing , link to
article at The Seattle Times |
|
|
|
|
01/23/07 |
Medarex and Compugen Announce Therapeutic Antibody Co-Development
Agreement |
|
|
|
|
|
Cell Therapeutics will pay $10.5 million to settle federal investigation, link to
article at The Seattle Times |
|
|
|
|
01/22/07 |
Thermo Fisher Scientific to Hold
Earnings Conference Call on Thursday, February 8, 2007 |
|
|
|
|
01/21/07 |
Data Recently Published in Mayo Clinic Proceedings Showed VYTORIN® (ezetimibe/simvastatin)
Superior to Lipitor (atorvastatin) in Reducing LDL "Bad" Cholesterol in
Patients with Type II Diabetes at the Dose Comparisons Studied |
|
|
|
|
|
FDA Approves New Indication for INVANZ® (ertapenem) for the Prevention
of Surgical Site Infections (SSI) following Elective Colorectal Surgery
in Adults |
|
|
|
|
01/18/07 |
GlaxoSmithKline initiates
head-to-head study of cervical cancer vaccines |
|
|
|
|
|
Pfizer’s Sutent® is Granted Full
Marketing Authorization for First-Line Use in Advanced Kidney Cancer in
the European Union |
|
|
|
|
|
Novartis receives US government contract to further develop a novel
antigen technology that could extend vaccine supplies in a pandemic
outbreak |
|
|
|
|
01/17/07 |
GlaxoSmithKline awarded $63 million HHS contract for
pandemic vaccine research and development: Company begins government and
retail shipments of its antiviral Relenza®
|
|
|
|
|
|
Geron:
Studies Show Geron’s Stem Cell Therapeutic for Spinal
Cord Injury Produces Nerve Growth Factors |
|
|
|
|
|
MDS:
First Patients in India Receive Innovative Treatment for Primary Liver
Cancer |
|
|
|
|
01/16/07 |
BG Medicine and Applied Biosystems to Collaborate on Molecular Medicine
Research |
|
|
|
|
|
Amgen Launches 2007 Breakaway from Cancer Initiative |
|
|
|
|
|
GlaxoSmithKline receives first
European approval for Wellbutrin XR® |
|
|
|
|
|
Lilly:
Enrollment Completed in Pivotal Phase III Study Comparing Prasugrel to
Clopidogrel in Patients With Acute Coronary Syndrome |
|
|
|
|
01/14/07 |
Splicing genes for safe food - Biotech assures protection on cellular
level, link to
article at The San Francisco Chronicle |
|
|
|
|
01/11/07 |
Bristol-Myers Squibb and AstraZeneca Announce Worldwide Collaboration to
Develop and Commercialize Diabetes Compounds |
|
|
|
|
|
Abbott
Private-Label Version of Abbott's XIENCE™V Drug-Eluting Coronary Stent
System Launches in Europe |
|
|
|
|
01/10/07 |
BMS:
ERBITUX® Phase III Study Meets Primary Endpoint In First-Line Treatment
of Metastatic Colorectal Cancer |
|
|
|
|
|
Roche:
NeoRecormon gains
European approval for convenient once weekly treatment of anaemia in
patients with solid cancers |
|
|
|
|
|
Applied Biosystems Announces New Molecular Tools to Speed Drug Discovery
Research |
|
|
|
|
01/09/07 |
U.S. Supreme Court ruling may alter biotech patent deals, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Court Rules in Favor of MedImmune, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Biogen
Idec Initiates Phase III Clinical Program of Oral Compound BG-12 for
Multiple Sclerosis |
|
|
|
|
|
GlaxoSmithKline commences tender offer to acquire Praecis
Pharmaceuticals |
|
|
|
|
01/08/07 |
Genentech Again Named One of FORTUNE's "100 Best Companies to Work For" |
|
|
|
|
|
Genentech and Seattle Genetics Announce Exclusive Global Licensing
Agreement for Development and Commercialization of SGN-40 |
|
|
|
|
|
Myriad Genetics
Announces Results of Phase 2 Prostate Cancer Trial |
|
|
|
|
|
Amniotic fluid holds stem cells full of potential, not controversy,
link to article at The Seattle Times |
|
|
|
|
|
Abbott m2000™
Instrument and Viral Load Tests for HIV-1 and HCV Approved in Canada |
|
|
|
|
01/07/07 |
Drug companies embracing biotech firms, link to
article at The San Francisco Chronicle |
|
|
|
|
01/04/07 |
Biogen
Idec to Acquire Syntonix |
|
|
|
|
|
Genentech Announces Positive Results from a Randomized Phase II Study of
Pertuzumab in Combination with Gemcitabine for Advanced Ovarian Cancer
|
|
|
|
|
01/03/07 |
Cytokinetics and Amgen Announce Strategic Alliance in Heart Failure
|
|
|
|
|
|
Bruker Daltonics Announces Selection of its RAID-M Chemical Agent
Detector for United States National Guard Program |
|
|
|
|
01/02/07 |
Scientists develop cows free of proteins causing mad cow disease
, link to article at The Seattle Times |
|
|
|
|
12/30/06 |
Biotech stocks are tops - Sector also produced Bay Area's worst
performers, link to
article at The San Francisco Chronicle |
|
|
|
|
12/24/06 |
Biotech firm gets rights to drug - Genentech buying technology for new
growth hormone |
|
|
|
|
12/22/06 |
GSK receives approvable letter for topical antibiotic, Altabax (retapamulin
ointment), 1% |
|
|
|
|
12/19/06 |
Geron’s Telomerase
Inhibitor Drug May Benefit Breast Cancer Patients Receiving Radiation
Therapy |
|
|
|
|
12/18/06 |
Exelixis and Bristol-Myers Squibb Sign New Collaboration Agreement to
Discover and Develop Novel Oncology Compounds |
|
|
|
|
12/15/06 |
Elan and
Biogen Idec Submit Supplemental Biologics License Application to the FDA
for the approval of TYSABRI® as a Treatment for Crohn's Disease |
|
|
|
|
|
Roche:
Tarceva receives
positive EU opinion for the treatment of metastatic pancreatic cancer |
|
|
|
|
|
Thermo Fisher Scientific Acquires Provider of Sample Extraction and
Liquid Chromatography Equipment |
|
|
|
|
12/14/06 |
CuraGen and TopoTarget Announce Expansion of Belinostat (PXD101)
Clinical Trial in Cutaneous T-cell Lymphoma (CTCL) |
|
|
|
|
|
Celera Identifies
Two Genetic Variations Predisposing Individuals to Increased Risk for
Psoriasis |
|
|
|
|
12/13/06 |
Amgen Announces $5 Billion Stock Repurchase Plan |
|
|
|
|
|
Abbott Acquires a Majority of Shares of Kos Pharmaceuticals, Inc.
|
|
|
|
|
12/12/06 |
VC funding may top $32 billion - Recovery from dot-com bust continues
with more money flowing into startups, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Roche:
Avastin shows positive
outcomes in patients with advanced kidney cancer |
|
|
|
|
12/11/06 |
Genentech to acquire a partner - $919 million deal to buy Tanox,
co-developer of the asthma medicine Xolair, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Roche: Xeloda meets
primary endpoint in multinational Phase III advanced colorectal cancer
study |
|
|
|
|
|
Child who received stem cells from aborted fetus on way home, link to
article at The San Francisco Chronicle |
|
|
|
|
12/10/06 |
Phase I/II
Data Support Continued Development of Biogen Idec's Novel Anti-CD23
Antibody for Chronic Lymphocytic Leukemia |
|
|
|
|
|
|
|
12/08/06 |
U.S. issues subpoena to HIV drug firm, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Genentech expands research - Swiss partnership marks foray into study of
Alzheimer's, link to
article at The San Francisco Chronicle |
|
|
|
|
12/07/06 |
California stem cell agency president to step down, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Gilead:
Gilead Sciences
Receives Subpoena from U.S. Department of Justice |
|
|
|
|
|
Eli Lilly and Company Submits New Drug Application for EVISTA for
Reduction of Invasive Breast Cancer Risk in Postmenopausal Women |
|
|
|
|
|
Medarex Announces FDA Fast Track Designations for Ipilimumab for the
Treatment of Metastatic Melanoma; Fast Track Designations for First-Line
Use in Combination With Chemotherapy and Second-Line Use as Monotherapy |
|
|
|
|
12/06/06 |
Roche:NT-proBNP
Test could save the North American healthcare system nearly 600 million
US dollars |
|
|
|
|
12/04/06 |
CV:
Regadenoson Meets Primary Endpoint in Second Phase 3 Clinical Trial |
|
|
|
|
11/29/06 |
Vaccine tests for hepatitis B are promising - Berkeley firm's shares up
29% on trial results, link to
article at The San Francisco Chronicle |
|
|
|
|
11/28/06 |
Roche:
Update on Tamiflu: no
increase in drug resistance observed |
|
|
|
|
|
November 28, 2006 Organon and Pfizer Discontinue Their Collaboration on
Asenapine |
|
|
|
|
11/25/06 |
Novartis:
Tyzeka(TM) receives US regulatory approval as a new
treatment for patients with chronic hepatitis B |
|
|
|
|
11/23/06 |
Novartis:
New Zelnorm® data demonstrate relief of multiple symptoms
of dysmotility-type dyspepsia |
|
|
|
|
11/22/06 |
District Court Judge Denies Preliminary Injunction in Ortho v. Amgen
Suit |
|
|
|
|
11/21/06 |
Pfizer Announces Settlement With Teva on Patents Covering Cancer
Medicine and Antibiotic |
|
|
|
|
11/18/06 |
Agilent Technologies Launches Life
Science and Chemical Analysis Centers of Excellence in California, India
and Europe |
| |
|
|
11/17/06 |
Gilead Sciences Completes Acquisition of Myogen |
| |
|
|
11/16/06 |
Neanderthal's fossil yields bits
of elusive DNA, link to
article at The San Francisco Chronicle |
|
|
|
|
|
FDA Approves Herceptin for the
Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
|
|
|
|
|
|
CuraGen and TopoTarget Announce
Initiation of NCI-sponsored Phase II Clinical Trial of PXD101 for
Myelodysplastic Syndrome |
|
|
|
|
|
Roche:
Statement - Label changes for Tamiflu |
|
|
|
|
11/15/06 |
454 Life Sciences and Max Planck Publish Sequence of One Million Base
Pairs of Neandertal DNA |
|
|
|
|
|
Pfizer:
Intensive Lipitor Therapy Reduced Heart Attack and Stroke by One-Third
in Patients with Chronic Kidney Disease, New Analysis Shows |
|
|
|
|
|
Millennium Closes Sale of $250.0
Million in Convertible Senior Notes |
|
|
|
|
11/14/06 |
Solexa, Illumina merging, link to
article at The San Francisco Chronicle |
|
|
|
|
|
Abbott's HUMIRA® (adalimumab) Receives FDA Approval for Inhibiting
Structural Joint Damage and Improving Physical Function in Patients with
Psoriatic Arthritis |
|
|
|
|
|
Data Shows ENBREL Provides Sustained Clinical
Improvements for People with Ankylosing Spondylitis for up to Three
Years |
|
|
|
|
|
Abbott Laboratories Commences Tender Offer for All Outstanding Shares of
Kos Pharmaceuticals, Inc. |
|
|
|
|
|
CuraGen and TopoTarget Announce Initiation of NCI-Sponsored Phase II
Trial of PXD101 for Ovarian Cancer |
|
|
|
|
11/13/06 |
Lilly:
Ruboxistaurin Reduced Vision Loss in Patients With
Moderate to Severe Non-Proliferative Diabetic Retinopathy in a New Study |
|
|
|
|
|
Merck Launches National
Advertising Campaign for GARDASIL®, Merck's New Cervical Cancer Vaccine |
|
|
|
|
11/11/06 |
Genentech to acquire a partner -
$919 million deal to buy Tanox, co-developer of the asthma medicine
Xolair, link to article
at The San Francisco Chronicle |
|
|
|
|
|
Biogen_Idec
Subsequent Course of Rituxan® Improved Outcomes in
Rheumatoid Arthritis Patients Who Inadequately Responded to TNF
Antagonist Therapy |
|
|
|
|
11/09/06 |
Merger of Thermo Electron and Fisher Scientific Completed, Forming
Thermo Fisher Scientific; - Video Available |
|
|
|
|
11/07/06 |
Genentech Announces Manufacturing Agreements With Lonza |
| |
|
|
11/06/06 |
BMS:
Survival Data Available from Two Randomized ERBITUX Studies in
Metastatic Colorectal Cancer |
| |
|
| |
GSK:
FDA issues approvable letter for Entereg® for POI |
| |
|
| |
Geron Licenses
Antigen Targeting Patents for Cancer Vaccine Program from Immunomic
Therapeutics |
| |
|
| |
Medarex Announces Board and Management Changes and Results of Previously
Announced Internal Investigation |
| |
|
|
11/04/06 |
Anthrax Vaccine Contract in Peril, link to
article at The San Francisco Chronicle |
| |
|
| |
AMG 706 Shows Activity in Phase 2 Study of Patients with Advanced
Imatinib-Resistant Gastrointestinal Stromal Tumors |
| |
|
|
11/03/06 |
FDA deals another blow to VaxGen Inc.'s anthrax vaccine struggle, link to
article at The San Francisco Chronicle |
| |
|
| |
Gilead Sciences Completes Acquisition of Raylo Chemicals Inc. |
| |
|
|
11/02/06 |
Bruker BioSciences Reports Significantly Improved Earnings and Strong
Revenue Growth for the Third Quarter of 2006 |
| |
|
|
11/01/06 |
Wine Extract Keeps Fat Mice Healthy, link to
article at The San Francisco Chronicle |
| |
|
|
10/31/06 |
Merck to Buy Biotech Firm for $1.1B, link to
article at The San Francisco Chronicle |
| |
|
|
10/30/06 |
BMS:
Study Shows Treatment with BARACLUDE® (Entecavir) Resulted in Greater
Viral Load Reductions Compared to Adefovir in Antiviral Naive Chronic
Hepatitis B E-Antigen Positive Patients |
| |
|
| |
GSK:
Eltrombopag significantly improved platelet count and allowed initiation
of antiviral therapy in majority of hepatitis C patients |
| |
|
|
10/29/06 |
New ethics rules lead government scientists to look for other jobs,
link to article at The Seattle Times |
| |
|
| |
|
|
10/26/06 |
Abbott's Humira® (Adalimumab) Granted FDA Priority Review for the
Treatment of Moderately to Severely Active Crohn's Disease |
| |
|
|
10/25/06 |
ImClone Appoints Icahn New Chairman, link to article at The San
Francisco Chronicle |
| |
|
| |
Novartis:
Tyzeka(TM) receives US regulatory approval as a new treatment for
patients with chronic hepatitis B |
| |
|
| |
MERCK:
CDC ADVISORY PANEL VOTES TO RECOMMEND MERCK'S SHINGLES VACCINE, ZOSTAVAX®,
FOR VACCINATION OF ADULTS AGE 60 AND OVER |
| |
|
|
10/24/06 |
Investors flipping over biotech, link to
article at The San Francisco Chronicle |
| |
|
| |
Myriad Genetics
Sponsors Clinical Trial in Pancreatic Cancer |
| |
|
|
10/23/06 |
New Phase III Data Shows Abbott's HUMIRA® (adalimumab) Induced Clinical
Remissions in Patients with Crohn's Disease Who Lost Response To, or
Were Intolerant To, Remicade® (infliximab) |
| |
|
| |
Novartis:
New Zelnorm® data demonstrate relief of multiple symptoms of dysmotility-type
dyspepsia |
| |
|
|
10/22/06 |
Myriad Genetics
Completes Enrollment in U.S. Phase 3 Clinical Trial of Flurizan for
Alzheimer's Disease |
| |
|
|
10/21/06 |
Merck, Schering-Plough Shares Climb, link to
article at The San Francisco Chronicle |
| |
|
|
10/20/06 |
BMS:
FDA Approves REYATAZ® (atazanavir sulfate) 300 mg Single Capsule
Formulation in Combination Therapy for Adults With HIV-1 Infection
- Formulation Marks The First One Capsule, Once Daily Protease Inhibitor
Dosing Option for Use With Ritonavir In Appropriate Patients - |
| |
|
| |
Applied Biosystems Announces Management Change |
| |
|
| |
Amgen:
U.S. District Court Denies Roche Motion to Dismiss Amgen Patent
Infringement Lawsuit |
| |
|
| |
GSK:
FDA approves new, once-a-day COREG CR™ for the treatment of three key
cardiovascular conditions |
| |
|
| |
Lilly Launches Phase III 'GALES' Trial of ALIMTA® (Pemetrexed for
Injection) in Small Cell Lung Cancer |
| |
|
| |
Science Magazine ranks
Roche No. 3 among Top Employers in the Biotech and Pharmaceutical
Industries |
| |
|
| |
Novartis:
Glivec® approved in the US for five rare life-threatening disorders with
limited treatment options |
| |
|
|
10/19/06 |
GeneBio and Goodlett Laboratory
Launch Collaboration |
| |
|
| |
Biogen
Idec Named Top Employer by Science Magazine |
| |
|
|
10/18/06 |
Abbott Reports Strong Third-quarter Results, Announces $2.5 Billion
Share Repurchase Program |
| |
|
| |
Switzerland to purchase GSK’s H5N1 vaccine for pre-pandemic use
|
| |
|
| |
Mexico Rejects Biotech Corn Planting, link to
article at The San Francisco Chronicle |
| |
|
|
10/17/06 |
AnorMed agrees to Genzyme's $580 m offer over Millennium bid, link to
article at The San Francisco Chronicle |
| |
|
| |
Millennium Issues Statement Regarding AnorMED Inc. |
| |
|
| |
Thermo Electron and Fisher Scientific Receive Early Termination from
FTC; Companies Respond to European Commission Review and Anticipate
Closing on Nov. 9 |
| |
|
| |
Roche´s nine-month
sales hit record high |
| |
|
| |
Roche and InterMune
sign agreement to collaborate on the research, development and
commercialization of Hepatitis C Protease Inhibitors |
| |
|
| |
MERCK:
FDA Approves Once-Daily JANUVIA™, the First and Only DPP-4 Inhibitor
Available in the United States for Type 2 Diabetes |
| |
|
| |
Roche and InterMune
sign agreement to collaborate on the research, development and
commercialization of Hepatitis C Protease Inhibitors |
| |
|
|
10/16/06 |
Laboratory Productivity Improves with First Commercial Mass
Spectrometry-based System for Amino Acid Analysis |
| |
|
| |
Medarex and PharmAthene Announce Phase I Results of Anthrax Therapeutic
Valortim |
| |
|
|
10/13/06 |
Roche files Herceptin
plus hormonal therapy for advanced HER2-positive breast cancer with
European Authorities |
| |
|
|
10/11/06 |
Genentech stock rebounds with news of drug approval , link to
article at The San Francisco Chronicle |
| |
|
| |
FDA Approves Avastin in Combination With Chemotherapy for First-Line
Treatment of Most Common Type of Lung Cancer |
| |
|
| |
Cat-Cloning Company to Close Its Doors, link to
article at The San Francisco Chronicle |
| |
|
| |
GlaxoSmithKline submits supplemental drug application in the USA for
Advair in COPD |
| |
|
| |
PharmAthene and Medarex Announce $1 Million Congressional Appropriation
for Continued Development of Anthrax Therapeutic Valortim(TM) |
| |
|
|
10/10/06 |
ImClone Chairman, Other Director Resign, link to
article at The San Francisco Chronicle |
| |
|
| |
Genentech profit up 58 percent on strong drugs sales |
| |
|
|
10/09/06 |
GlaxoSmithKline seeks European approval for Tykerb® (lapatinib
ditosylate) for the treatment of advanced breast cancer |
| |
|
|
10/03/06 |
Gilead's purchase expands its scope - Foster City company hopes Myogen
buy will lead to growth, link to
article at The San Francisco Chronicle |
| |
|
| |
Americans Share Nobel Prize in Medicine, link to
article at The San Francisco Chronicle |
| |
|
| |
Genentech and CGI Pharmaceuticals Enter Into Exclusive Global Strategic
Alliance for Potential Products in Multiple Oncology and Autoimmune
Indications |
| |
|
|
10/02/06 |
UCB and
Biogen Idec to Collaborate on Oral Multiple Sclerosis Therapy |
| |
|
| |
GSK:
FDA grants priority review for Arixtra® (fondaparinux sodium) in the
treatment of acute coronary syndromes |
| |
|
| |
Additional benefit
for patients resulting from combination therapies with Roche cancer
medicines |
| |
|
| |
Tamiflu readily
available for 2006/2007 influenza season |
| |
|
|
9/29/06 |
Amgen to Acquire Avidia, a Privately Held Biopharmaceutical Company in
the San Francisco Bay Area |
| |
|
| |
FDA Approves Two New Indications for Rituxan in Patients With
Non-Hodgkin’s Lymphoma |
| |
|
| |
Lilly Announces FDA Requirement of Additional Clinical Trial Before
Ruboxistaurin Could Be Approved for Treatment of Diabetic Retinopathy |
| |
|
| |
Pfizer's Anti-Smoking Pill Champix®
Approved In Europe |
| |
|
|
9/28/06 |
Bristol-Myers Squibb And Gilead Sciences Establish Agreement To
Commercialize ATRIPLA™ (efavirenz 600 mg/ emtricitabine 200 mg/
tenofovir disoproxil fumarate 300 mg) In Canada--If Approved,
Product Would Be the First Once-Daily Single Tablet Regimen for HIV-1
Infection in Adults in Canada |
| |
|
| |
Novartis:
New data for FTY720 - aiming to become the first orally effective
multiple sclerosis treatment - show sustained benefits over two years |
| |
|
|
9/27/06 |
FibroGen deal a boost for Mission Bay - Big biotech firm is helping make
mayors' vision a reality, link to
article at The San Francisco Chronicle |
| |
|
| |
Amgen:
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal
Cancer |
| |
|
|
9/26/06 |
GeneBio and Insilicos Sign Global Distribution Agreement
|
| |
|
|
9/18/06 |
GlaxoSmithKline seeks US approval for Tykerb® (lapatinib ditosylate) for
the treatment of advanced breast cancer |
| |
|
|
9/16/06 |
Beijing eyes biotech business - Scientists are returning to China after
working in the United States, link to
article at The San Francisco Chronicle |
| |
|
|
9/15/06 |
Abbott Voluntarily Issues a Nationwide Recall For One Lot of Alimentum,
Two Lots of Similac Advance Liquid Infant Formula Ready-to-feed 32-ounce
Plastic Bottles and One Lot of Hospital Discharge Kits |
| |
|
|
9/14/06 |
Biogen
Idec and Mondobiotech Sign Collaboration and Licensing Agreement to
Develop and Commercialize Aviptadil for Pulmonary Arterial Hypertension |
| |
|
|
9/13/06 |
Bristol-Myers Squibb Company And Medivir AB Announce Worldwide
Collaboration To Develop And Commercialize MIV-170 For The Treatment Of
HIV-1 Infection In Adults |
| |
|
|
9/11/06 |
Genentech Receives Complete Response Letter From FDA for Avastin in
Metastatic Breast Cancer |
| |
|
|
09/05/06 |
Applied Biosystems Anounces Settlement of Legal Disputes with Promega
Corporation |
| |
|
| |
Abbott:
Abbott's XIENCE V™ Drug-eluting Coronary Stent Superior to TAXUS® Stent
in Spirit II Clinical Trial |
| |
|
| |
GlaxoSmithKline and Adolor report top line results from phase 3 studies
of Alvimopan (Entereg/Entrareg®) |
| |
|
|
08/31/06 |
BMS:
Preliminary Injunction Ordered In PLAVIX® Patent Infringement Case
Apotex To Halt Sales Of Unauthorized Generic |
|
|
|
08/28/06 |
Genentech
and Biogen Idec Announce Positive Results From a Phase II Trial of
Rituxan in Relapsing-Remitting Multiple Sclerosis |
|
|
|
08/27/06 |
Bruker
Daltonics Introduces Next-Generation Horizontal Top-of-the-Line
MALDI-TOF/TOF Mass Spectrometer at IMSC |
|
|
|
08/18/06 |
Eli
Lilly and Company Announces Approvable Letter Issued by FDA for Arxxant™
(ruboxistaurin mesylate) |
|
|
|
08/17/06 |
Xenogen
Biosciences Announces Target Validation Collaboration Agreement with
Schering-Plough |
|
|
|
BMS:
FDA
Approves New Indication For PLAVIX® (clopidogrel bisulfate) Offering
New Option For Patients With Most Severe Type Of Heart Attack-- |
|
|
|
Genentech
Foundation for Biomedical Sciences Awards $1.2 Million to Health Science
Education Programs in the Bay Area |
|
|
|
08/15/06 |
Biogen
Idec Researchers Identify Potential New Pathway in Rheumatoid Arthritis
Disease Process |
|
